» Authors » Eleni Stamellou

Eleni Stamellou

Explore the profile of Eleni Stamellou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 106
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonnin-Marquez A, Jankowski J, Maas S, Hermann J, Kahles F, Lellig M, et al.
Kidney Int . 2025 Feb; PMID: 40010491
Chronic kidney disease (CKD) substantially heightens the likelihood of cardiovascular events, in part due to the impaired functionality of high-density lipoprotein (HDL) and its connection with atherosclerosis. Here, 82 patients...
2.
Gori M, Abelardo D, Pitino A, Stamellou E, Bratsiakou A, Marino C, et al.
Int Urol Nephrol . 2024 Dec; PMID: 39621215
Randomized clinical trials (RCTs) are pivotal in medical research, offering critical evidence on the efficacy and safety of treatments. This paper explores the distinct purposes and designs of superiority, non-inferiority,...
3.
Georgopoulos C, Duni A, Stamellou E, Kitsos A, Gouva C, Dounousi E
Hemodial Int . 2024 Oct; 29(1):6-16. PMID: 39422162
Introduction: Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease-mineral and bone disorder has been linked to...
4.
Stamellou E, Sterzer V, Alam J, Roumeliotis S, Liakopoulos V, Dounousi E
Int J Mol Sci . 2024 Aug; 25(16). PMID: 39201324
Premenopausal women generally exhibit lower blood pressure and a lower prevalence of hypertension than men of the same age, but these differences reverse postmenopause due to estrogen withdrawal. Sexual dimorphism...
5.
Stamellou E, Nadal J, Hendry B, Mercer A, Seikrit C, Bechtel-Walz W, et al.
Clin Kidney J . 2024 Aug; 17(8):sfae230. PMID: 39149090
Background: The importance of albuminuria as opposed to proteinuria in predicting kidney outcomes in primary immunoglobulin A nephropathy (IgAN) is not well established. Methods: From 2010 to 2012, 421 patients...
6.
Roumeliotis S, Divani M, Stamellou E, Liakopoulos V
Curr Genomics . 2024 Aug; 25(3):153-157. PMID: 39086997
Diabetic Kidney Disease (DKD) remains the leading cause of Chronic and End Stage Kidney Disease (ESKD) worldwide, with an increasing epidemiological burden. However, still, the disease awareness remains low, early...
7.
Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M, et al.
Clin Kidney J . 2024 Jul; 17(7):sfae131. PMID: 38989280
Background: Focal segmental glomerulosclerosis (FSGS) can lead to kidney failure in adults. This study examines the progression of FSGS in the German Chronic Kidney Disease (GCKD) cohort. Methods: The GCKD...
8.
Koutlas V, Tzalavra E, Tatsis V, Pappas C, Vovlianou S, Bellos S, et al.
World J Transplant . 2024 Jul; 14(2):90825. PMID: 38947968
Background: Kidney transplantation leads to continuous improvement in the survival rates of kidney transplant recipients (KTRs) and has been established as the treatment of choice for patients with end-stage kidney...
9.
Neofytou I, Stamou A, Demopoulos A, Roumeliotis S, Zebekakis P, Liakopoulos V, et al.
Nutrients . 2024 Jun; 16(12). PMID: 38931153
Patients with chronic kidney disease (CKD) suffer disproportionately from a high burden of cardiovascular disease, which, despite recent scientific advances, remains partly understood. Vascular calcification (VC) is the result of...
10.
Stamellou E, Noels H, Floege J
Kidney Int . 2024 Jun; 106(1):21-23. PMID: 38906653
Chronic hemodialysis patients exhibit an excessive cardiovascular risk and a marked increase in both thromboembolism and bleeding episodes. Factor XI inhibition may provide anticoagulation, with a low risk of bleeding,...